Table 2.
Characterization of adverse events for all data and ASA 2-only sub-analysis.
| Adverse events for all data | Adverse events for ASA 2 only | ||||||
|---|---|---|---|---|---|---|---|
| NAAP | GA | p-Value | NAAP | GA | p-Value | ||
| (n = 496) | (n = 433) | (n = 470) | (n = 290) | ||||
| Respiratory | Respiratory | ||||||
| Hypoxia | 12 | 54 | 0.0004 | Hypoxia | 12 | 26 | 0.0001 |
| Lowest O2 sat | 85% | 50% | Lowest O2 sat (%) | 85 | 62 | ||
| Desaturation <90% lasting longer than 1 min | 0 | 11 | 0.0004 | Desaturation <90% lasting longer than 1 min | 0 | 5 | 0.007 |
| Positive pressure ventilation | 9 | 0 | 0.005 | Positive pressure ventilation | 9 | 0 | 0.005 |
| Bag mask ventilation | 2 | 0 | 0.502 | Bag mask ventilation | |||
| Bronchospasm | 1 | 0 | 1.000 | Bronchospasm | |||
| Laryngospasm | 7 | 1 | 0.052 | Laryngospasm | 7 | 0 | 0.037 |
| Cardiac | Cardiac | ||||||
| Arrhythmia | 1 | 1 | 1.000 | Arrhythmia | 1 | 1 | 1.000 |
| Syncope | 1 | 0 | Syncope | 1 | 0 | ||
| Gacardiacstrointestinal | Gastrointestinal | ||||||
| Treatment with antiemetics | 2 | 7 | 0.06 | Treatment with antiemetics | 2 | 6 | 0.031 |
| Hematemesis | 1 | 0 | 1.000 | Hematemesis | 0 | 0 | |
| Other | Other | ||||||
| Urinary retention | 0 | 1 | 0.466 | Urinary retention | 0 | 0 | 1.000 |
| ER visit | 1 | 3 | 0.253 | ER visit | 1 | 2 | |
| Admission | 0 | 1 | 0.466 | Admission | 0 | 1 | |